Vericel Corp — Investor Relations & Filings
Vericel Corporation is a biopharmaceutical company that develops, manufactures, and commercializes advanced cell therapies for the sports medicine and severe burn care markets. The company's portfolio is centered on autologous (patient-specific) cell-based products. Key commercial products include MACI® (autologous cultured chondrocytes on porcine collagen membrane), a tissue-engineered product for the repair of symptomatic cartilage defects of the knee, and Epicel® (cultured epidermal autografts), a permanent skin replacement for patients with severe burns. Additionally, Vericel holds the exclusive North American commercial rights for NexoBrid®, a biological orphan product used for the removal of eschar in adults with deep partial-thickness or full-thickness thermal burns.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Director's Dealing 2023 | 2023-04-27 | English | |
| ANNUAL REPORT TO SECURITY HOLDERS | 2023-03-23 | English | |
| DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS | 2023-03-23 | English | |
| DEFINITIVE PROXY STATEMENT | 2023-03-23 | English | |
| PRIMARY DOCUMENT | 2023-03-03 | English | |
| 10-K | 2023-02-23 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 9927586 | Director's Dealing 2023 | 2023-04-27 | English | ||
| 9927584 | ANNUAL REPORT TO SECURITY HOLDERS | 2023-03-23 | English | ||
| 9927587 | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS | 2023-03-23 | English | ||
| 9927591 | DEFINITIVE PROXY STATEMENT | 2023-03-23 | English | ||
| 9927589 | PRIMARY DOCUMENT | 2023-03-03 | English | ||
| 9927588 | 10-K | 2023-02-23 | English | ||
| 9927592 | 8-K | 2023-02-23 | English | ||
| 9927593 | PRIMARY DOCUMENT | 2023-02-23 | English | ||
| 9927594 | PRIMARY DOCUMENT | 2023-02-23 | English | ||
| 9927595 | PRIMARY DOCUMENT | 2023-02-23 | English | ||
| 9927596 | PRIMARY DOCUMENT | 2023-02-23 | English | ||
| 9927597 | PRIMARY DOCUMENT | 2023-02-23 | English | ||
| 9927598 | PRIMARY DOCUMENT | 2023-02-23 | English | ||
| 9927599 | PRIMARY DOCUMENT | 2023-02-14 | English | ||
| 9927600 | PRIMARY DOCUMENT | 2023-02-14 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Vericel Corp via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31799/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31799 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31799 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31799 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31799}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Vericel Corp (id: 31799)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.